Topspin Fund L.P.

This profile gathers the share dealings of Topspin Fund L.P. across 3 companies, led by Oric Pharmaceuticals, Inc., Constellation Pharmaceuticals Inc and RAPT Therapeutics, Inc. The record holds 10 filings, for trades running from 23 July 2018 to 4 November 2020.

Market trades split into 1 purchase (€4.5M) and 2 sales. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2020: no purchases and 2 sales on the market.

The latest filing, published on 5 November 2020, reports an open-market sale in Oric Pharmaceuticals, Inc. The most recent open-market purchase was published on 15 November 2019, 2,551 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.